Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Pregnancy in Sub-Saharan Africa: A 6-Country Retrospective Cohort Analysis
Jean B Nachega,Nadia A Sam-Agudu,Rhoderick N Machekano,Philip J Rosenthal,Sonja Schell,Liesl de Waard,Adrie Bekker,Onesmus W Gachuno,John Kinuthia,Nancy Mwongeli,Samantha Budhram,Valerie Vannevel,Priya Somapillay,Hans W Prozesky,Jantjie Taljaard,Arifa Parker,Elizabeth Agyare,Akwasi Baafuor Opoku,Aminatu Umar Makarfi,Asara M Abdullahi,Chibueze Adirieje,Daniel Katuashi Ishoso,Michel Tshiasuma Pipo,Marc B Tshilanda,Christian Bongo-Pasi Nswe,John Ditekemena,Lovemore Nyasha Sigwadhi,Peter S Nyasulu,Michel P Hermans,Musa Sekikubo,Philippa Musoke,Christopher Nsereko,Evans K Agbeno,Michael Yaw Yeboah,Lawal W Umar,Mukanire Ntakwinja,Denis M Mukwege,Etienne Kajibwami Birindwa,Serge Zigabe Mushamuka,Emily R Smith,Edward J Mills,John Otokoye Otshudiema,Placide Mbala-Kingebeni,Jean-Jacques Muyembe Tamfum,Alimuddin Zumla,Aster Tsegaye,Alfred Mteta,Nelson K Sewankambo,Fatima Suleman,Prisca Adejumo,Jean R Anderson,Emilia V Noormahomed,Richard J Deckelbaum,Jeffrey S A Stringer,Abdon Mukalay,Taha E Taha,Mary Glenn Fowler,Judith N Wasserheit,Refiloe Masekela,John W Mellors,Mark J Siedner,Landon Myer,Andre-Pascal Kengne,Marcel Yotebieng,Lynne M Mofenson,Eduard Langenegger,AFREhealth Research Collaboration on COVID-19 and Pregnancy
DOI: https://doi.org/10.1093/cid/ciac294
2022-11-30
Abstract:Background: Few data are available on COVID-19 outcomes among pregnant women in sub-Saharan Africa (SSA), where high-risk comorbidities are prevalent. We investigated the impact of pregnancy on SARS-CoV-2 infection and of SARS-CoV-2 infection on pregnancy to generate evidence for health policy and clinical practice. Methods: We conducted a 6-country retrospective cohort study among hospitalized women of childbearing age between 1 March 2020 and 31 March 2021. Exposures were (1) pregnancy and (2) a positive SARS-CoV-2 RT-PCR test. The primary outcome for both analyses was intensive care unit (ICU) admission. Secondary outcomes included supplemental oxygen requirement, mechanical ventilation, adverse birth outcomes, and in-hospital mortality. We used log-binomial regression to estimate the effect between pregnancy and SARS-CoV-2 infection. Factors associated with mortality were evaluated using competing-risk proportional subdistribution hazards models. Results: Our analyses included 1315 hospitalized women: 510 pregnant women with SARS-CoV-2, 403 nonpregnant women with SARS-CoV-2, and 402 pregnant women without SARS-CoV-2 infection. Among women with SARS-CoV-2 infection, pregnancy was associated with increased risk for ICU admission (adjusted risk ratio [aRR]: 2.38; 95% CI: 1.42-4.01), oxygen supplementation (aRR: 1.86; 95% CI: 1.44-2.42), and hazard of in-hospital death (adjusted sub-hazard ratio [aSHR]: 2.00; 95% CI: 1.08-3.70). Among pregnant women, SARS-CoV-2 infection increased the risk of ICU admission (aRR: 2.0; 95% CI: 1.20-3.35), oxygen supplementation (aRR: 1.57; 95% CI: 1.17-2.11), and hazard of in-hospital death (aSHR: 5.03; 95% CI: 1.79-14.13). Conclusions: Among hospitalized women in SSA, both SARS-CoV-2 infection and pregnancy independently increased risks of ICU admission, oxygen supplementation, and death. These data support international recommendations to prioritize COVID-19 vaccination among pregnant women.